Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteer, Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03919669
What this trial is testing

A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 27
Early research (Phase 1)Study completedNCT00439010
What this trial is testing

Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects

Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30
Early research (Phase 1)Study completedNCT01035164
What this trial is testing

Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers

Who this might be right for
Positron-Emission TomographyAlzheimer's Disease
Bayer 25
Early research (Phase 1)Study completedNCT01702467
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 27
Early research (Phase 1)Study completedNCT05628636
What this trial is testing

AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Who this might be right for
Alzheimer Disease
Cerecin 18
Very early researchStudy completedNCT04474405
What this trial is testing

Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 36
Early research (Phase 1)Study completedNCT03545789
What this trial is testing

Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

Who this might be right for
Healthy VolunteersAlzheimer DiseaseProgressive Supranuclear Palsy
Invicro 16
Not applicableStudy completedNCT06027320
What this trial is testing

The Retain Your Brain Health Study (RetainYourBrain.com)

Who this might be right for
Alzheimer DiseaseDementiaHealthy Participants+1 more
Retain Health, Inc 992
Testing effectiveness (Phase 2)Looking for participantsNCT05395624
What this trial is testing

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Parkinson Disease (PD)Alzheimer Disease (AD)+1 more
Ashvattha Therapeutics, Inc. 65
Very early researchStudy completedNCT04462029
What this trial is testing

Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers

Who this might be right for
Dementia Alzheimers
Boryung Pharmaceutical Co., Ltd 18
Early research (Phase 1)Ended earlyNCT00605046
What this trial is testing

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 1
Early research (Phase 1)Study completedNCT00287248
What this trial is testing

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 38
Early research (Phase 1)UnknownNCT06367426
What this trial is testing

A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People

Who this might be right for
Alzheimer Disease
Pharmacobio 100
Early research (Phase 1)Study completedNCT06511570
What this trial is testing

A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 28
Not applicableStudy completedNCT00029120
What this trial is testing

Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder

Who this might be right for
Alzheimer DiseaseDementiaMemory Disorder+1 more
National Institute of Mental Health (NIMH) 450
Early research (Phase 1)Study completedNCT04476303
What this trial is testing

Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants

Who this might be right for
Alzheimer's Disease
BeyondBio Inc. 88
Not applicableStudy completedNCT05999916
What this trial is testing

Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants

Who this might be right for
Healthy ParticipantsHealthy Population
Bottneuro AG 8
Early research (Phase 1)Ended earlyNCT01924858
What this trial is testing

A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 4
Early research (Phase 1)Study completedNCT01227252
What this trial is testing

A Safety Study of LY2886721 Multiple Doses in Healthy Subjects

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 42
Early research (Phase 1)Study completedNCT03375697
What this trial is testing

Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 72
Next Page